Glaxosmithkline Pharmaceuticals Ltd Q4 FY2025-2026 Results: Summary

Revenue
₹1,031.25Cr
Net Profits
₹277.86Cr
Net Profit Margins
26.94%
Highlights
Revenue:

Glaxosmithkline Pharmaceuticals Ltd’s revenue jumped 1.6% since last year same period to ₹1,031.25Cr in the Q4 2025-2026. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated -5.51% fall in its revenue since last 3-months.

Net Profits:

Glaxosmithkline Pharmaceuticals Ltd’s net profit jumped 5.7% since last year same period to ₹277.86Cr in the Q4 2025-2026. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated -6.01% fall in its net profits since last 3-months.

Net Profit Margins:

Glaxosmithkline Pharmaceuticals Ltd’s net profit margin jumped 4.04% since last year same period to 26.94% in the Q4 2025-2026. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated -0.53% fall in its net profit margins since last 3-months.

FAQs

What was the revenue for Glaxosmithkline Pharmaceuticals Ltd in Q4 results 2025?

The revenue for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2025 was ₹1,031.25Cr.

What was the net profit for Glaxosmithkline Pharmaceuticals Ltd in Q4 results 2025?

The net profit for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2025 was ₹277.86Cr.

What was the net profit margin for Glaxosmithkline Pharmaceuticals Ltd in Q4 results 2025?

The net profit margin for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2025 was 26.94%.

What was the revenue for Glaxosmithkline Pharmaceuticals Ltd in Q4 results 2024?

The revenue for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2024 was ₹1,015.05Cr.

What was the net profit for Glaxosmithkline Pharmaceuticals Ltd in Q4 results 2024?

The net profit for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2024 was ₹262.87Cr.

What was the net profit margin for Glaxosmithkline Pharmaceuticals Ltd in Q4 results 2024?

The net profit margin for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2024 was 25.90%.